COVID-19 Pandemic Enhancing the Growth of Single-Use Bioprocessing Device Market

27 July 2021

The rising incidence of the elderly population is prone to several chronic diseases and creating a high demand for biopharmaceutical manufacturing. The majority of biomanufacturing companies rely on advanced technology such as single-use systems to develop the vaccine. The sudden outbreak of COVID-19 boosted the demand for the single-use bioprocessing devices market. The ongoing robust R&D activities and clinical studies on the COVID-19 vaccine are encouraging various stakeholders to use single-use bioprocessing technology. Modalities such as COVID-19 vaccine requirement, cell and gene therapies, and monoclonal antibodies are likely to influence the growth of the single-use bioprocessing device market. Single-use solutions have replaced a significant portion of traditional biopharmaceutical manufacturing practices and this trend is expected to increase in the coming years. The acceptance of single-use bioprocessing among CMOs is has been increasing in recent years. Various R&D activities conducted by pharmaceutical companies are contributing to rising utilization of single-use systems.

The global single-use bioprocessing market is segmented into five regions, including North America, Europe, APAC, Latin America, and the Middle East & Africa. In North America countries such as the US and Canada are the major revenue generator in the single-use bioprocessing device market. According to Arizton’s research, the global capacity of biopharmaceutical manufacturing demonstrated that North America will dominate the market in terms of manufacturing facilities. New product launches, continuous strategic acquisitions, and collaborations is expected to accelerate the growth of the single-use bioprocessing market in the region. The single-use bioprocessing device market in North America to witness revenue growth of approximately USD 5 billion by 2026.

Read: Single-use Bioprocessing Market Global Outlook and Forecast 2021-2026

Strategic Acquisitions and Partnerships to Boom in the Single-Use Bioprocessing Device Market

Single-use bioprocessing device market players are witnessing a rising number of acquisitions and partnerships by several medium and small-sized companies to strengthen their position in the global market. Manufacturers are focusing more on developing their products with high-quality and better efficiency. Companies are implementing acquisitions and partnerships as the main strategy to sustain in the competitive market. Players aim at expanding their product portfolio across the supply chain, including upstream and downstream procedures. Thermo Fisher Scientific is actively involving in strategic acquisitions to develop broad product portfolios. For instance, on April 30, 2019, the company acquired Brammer Bio for around USD 2 billion, which helped it to expand its contract manufacturing capabilities. The company’s high-quality product offerings, strong brand image, and established customer relationships will provide strong growth opportunities to continue extending its leadership position in the global single-use bioprocessing market.

Did you know, reduced water consumption and lesser environment positively impacting single-use technologies? Single-use devices reduce the need for large quantities of water and energy associated with it. SUBs usually reduce energy consumption by 29% and water consumption up to 87%. Various studies estimated that the reduced environmental impact is surging the growth of the single-use bioprocessing market. In terms of footprint and space utilization, single-use technology requires a small area and less cleanroom space, resulting in low utilities and HVAC costs, creating a high demand for the single-use bioprocessing device market across the globe.

ReadRegenerative Medicine Market Global Outlook and Forecast 2021-2026

Overlook About the Competition Among the Players in Single-Use Bioprocessing Device Market

The growing interest and high demand from major biopharmaceutical companies for single-use technologies have encouraged players to undertake several business strategies to maintain a competitive edge over other players in the single-use bioprocessing market. Vendors, especially Danaher, Merck KGaA, Sartorius Stedim Biotech, Avantor, and Thermo Fisher Scientific are actively engaged in inorganic growth strategies. Players making huge investments to expand their existing single-use product portfolios and enhance their brand awareness among end-users in the market. At the onset of COVID-19 vendors are targeting vaccine developers and offering them custom and flexible single-use bioprocessing technologies as per their requirements.

Single-use systems were found to prevent cross-contamination and decreased energy & water consumption thereby, soaring the demand for single-use bioprocessing technology in the global market. Flexibility, scalability, reduced capital investment, low-utility costs, and reduced risk of contamination are the major advantages offered by single-use solutions to end-users. It was estimated that compared to biotherapeutic developers, CMOs participated more in introducing new products in the market. with the expansion of biopharmaceutical manufacturing and research activities across the world, huge changes are expected to be observed in the future.

Read: Antimicrobial Wound Dressings Market Global Outlook and Forecast 2021-2026

FAQs about the Global Single-Use Bioprocessing Device Market:

Q. What is the market size of the single-use bioprocessing device?

A. The global single-use bioprocessing device market to reach over USD 12 billion by 2026.

Q. What is the market growth of the single-use bioprocessing device?

A. The global single-use bioprocessing device market is projected to grow at a CAGR of around 17% during the forecast period.

Q. What is the market segmentation of the single-use bioprocessing device?

A. The global single-use bioprocessing device market is segmented by product, application, end-user, method, and geography.

Q. What is the market insight of the single-use bioprocessing device?

A. contract manufacturing organizations (CMO) are likely to grow at the fastest CAGR of over 17% during 2020–2026 because of the high adoption of SUBs by CMOs for biopharmaceuticals manufacturing.

Q. What are the major regions in the single-use bioprocessing device market?

A. The major regions in the global single-use bioprocessing device market include APAC, North America, Europe, Latin America, and Middle East & Africa.

Sep 01, 2021

Top 4 Vendors in the North America Window and Door Industry

The North America windows and doors industry is continuously growing with the presence of a large nu...

Sep 01, 2021

Is the Advent of Ecofriendly Products Impacting the Drain Cleaners Market?

The rise of commercial spaces in developed countries is enhancing the demand for drain cleaners. The...

Sep 01, 2021

Growth Opportunities in the Road Marking Materials Market

The early usage of marking materials was limited to the median line which demarcated roads as incomi...